Active — Not RecruitingNot Applicable

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

France205 participantsStarted 2020-07-03

Plain-language summary

Patients older than 60 years are more and more transplanted. Comprehensive geriatric assessment (CGA) have been developed and are currently used in patients with cancer, it has been correlated with the prognosis. There is still few data in transplanted patients and the aim of this study is to assess these patients before and after transplantation in order to monitor their general health and quality of life (QOF) and correlate them to the prognostic.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 60 years or more at time of transplantation * Patient receiving a hematopoietic stem cell allograft for myeloid hemopathy (myeloid acute leukemia, myelodysplastic syndrome, Myeloproliferative neoplasm) or for an Acute lymphoblastic leukemia * No opposition to participate Exclusion Criteria: * Patient opposed to the protocol * Vulnerable patients protected by curatorship or administrative supervision * Patients not covered by a social security scheme

What they're measuring

Overall survival

Timeframe: at one year post allogeneic hematopoietic stem cell transplantation

Trial details

NCT IDNCT04375579

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-17

View on ClinicalTrials.gov More Stem Cell Transplant trials